U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07478536) titled 'Testing a New Prostate Cancer Check (Stockholm3) in Men Who Are Being Monitored' on March 12.
Brief Summary: The CHAS3 trial studies whether the Stockholm3 blood test can reliably detect if prostate cancer becomes more aggressive in men who are being carefully monitored instead of treated right away (active surveillance). The goal is to see if this test can help doctors safely follow patients with fewer invasive procedures, such as repeated biopsies.
Study Start Date: April 01
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Active Surveillance for Prostate Cancer
Intervention:
DIAGNOSTIC_TEST: Stockholm3
Predictive valu...